Product
소개
GoliBridge ELISA Kit For Simponi Biosimilar Comparison
Complete kit for the systematic 3-D conformational comparability analysis of
Simponi biosimilar molecule to Golimumab (Simponi trade name)
Golimumab is a human monoclonal antibody which is used as an immunosuppressive drug and marketed under the brand name Simponi. Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor. Golimumab was developed by Janssen Biotech, Inc. (formerly CentocorBiotech, Inc.) which also markets the product in the United States.
This kit will allow for conformational comparison between Simponi Biosimilars and authentic Golimumab.
주문정보
관련자료